Intelligent Bio Solutions
INBS
9 hedge funds and large institutions have $202K invested in Intelligent Bio Solutions in 2026 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
13% more funds holding
Funds holding: 8 → 9 (+1)
4.01% less ownership
Funds ownership: 7.58% → 3.58% (-4%)
46% less capital inflows, than outflows
Capital inflows: $187K | Capital outflows: $345K
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$149K |
| 2 |
StoneX Group
New York
|
+$23.9K |
| 3 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$14.5K |
| 4 |
JP Morgan Chase
New York
|
+$28 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Armistice Capital
New York
|
-$325K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$9.31K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$6.3K |
| 4 |
Tower Research Capital (TRC)
New York
|
-$4.1K |
| 5 |
Barclays
London,
United Kingdom
|
-$326 |
INBS Hedge Fund Activity: Q3 2026 in Review
9 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q3 2026, worth a combined $202K — down 51% from $416K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new INBS positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $149K. The largest seller was Armistice Capital, exiting entirely with an estimated $325K sold.
- 9 institutional investors held Intelligent Bio Solutions (INBS) as of Q3 2026, up from 8 in Q2 2026.
- Funds reported $202K of Intelligent Bio Solutions stock for Q3 2026, down 51% quarter-over-quarter.
- 3 funds opened new Intelligent Bio Solutions positions in Q3 2026 and 2 closed out, a net change of +1 holder.
- The largest Intelligent Bio Solutions buyer in Q3 2026 was Alyeska Investment Group, an estimated $149K added.
- The largest Intelligent Bio Solutions seller in Q3 2026 was Armistice Capital, an estimated $325K sold.
Based on aggregated 13F filings for Q3 2026.